Search Legislation

Commission Implementing Regulation (EU) 2018/917Show full title

Commission Implementing Regulation (EU) 2018/917 of 27 June 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, carvone, chlorpropham, cyazofamid, desmedipham, dimethoate, dimethomorph, diquat, ethephon, ethoprophos, etoxazole, famoxadone, fenamidone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, Gliocladium catenulatum strain: J1446, isoxaflutole, metalaxyl-m, methiocarb, methoxyfenozide, metribuzin, milbemectin, oxasulfuron, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, pymetrozine and s-metolachlor (Text with EEA relevance)

 Help about what version

What Version

 Help about opening options

Opening OptionsExpand opening options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Status:

This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 15, Diquat, the date is replaced by ‘30 June 2019’;

(2)

in the sixth column, expiration of approval, of row 23, Pymetrozine, the date is replaced by ‘30 June 2019’;

(3)

in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2019’;

(4)

in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2019’;

(5)

in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2019’;

(6)

in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2019’;

(7)

in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2019’;

(8)

in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2019’;

(9)

in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2019’;

(10)

in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2019’;

(11)

in the sixth column, expiration of approval, of row 78, Chlorpropham, the date is replaced by ‘31 July 2019’;

(12)

in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2019’;

(13)

in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2019’;

(14)

in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2019’;

(15)

in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2019’;

(16)

in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2019’;

(17)

in the sixth column, expiration of approval, of row 96, Methoxyfenozide, the date is replaced by ‘31 July 2019’;

(18)

in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2019’;

(19)

in the sixth column, expiration of approval, of row 98, Gliocladium catenulatum strain: J1446, the date is replaced by ‘31 July 2019’;

(20)

in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2019’;

(21)

in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2019’;

(22)

in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2019’;

(23)

in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2019’;

(24)

in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2019’;

(25)

in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2019’;

(26)

in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2019’;

(27)

in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2019’;

(28)

in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2019’;

(29)

in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2019’;

(30)

in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2019’;

(31)

in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2019’;

(32)

in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2019’;

(33)

in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2019’;

(34)

in the sixth column, expiration of approval, of row 155, ethoprophos, the date is replaced by ‘31 July 2019’;

(35)

in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2019’;

(36)

in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2019’;

(37)

in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2019’;

(38)

in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2019’;

(39)

in the sixth column, expiration of approval, of row 165, Carvone, the date is replaced by ‘31 July 2019’;

(40)

in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2019’;

(41)

in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2019’;

(42)

in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2019’.

Back to top

Options/Help